Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Tuesday, May 28, 2024    
Asian Paints  2910.45  (1.30%)
 
Axis Bank  1182.40  (-0.41%)
 
Bajaj Finance  6874.50  (-0.28%)
 
Bajaj Finserv  1600.00  (0.31%)
 
Bharti Airtel  1370.55  (-0.95%)
 
HCL Technologi..  1358.25  (0.29%)
 
HDFC Bank  1530.50  (0.17%)
 
Hind. Unilever  2393.30  (0.40%)
 
ICICI Bank  1126.90  (-0.28%)
 
IndusInd Bank  1458.55  (-0.48%)
 
Infosys  1466.20  (-0.37%)
 
ITC  428.90  (-0.60%)
 
JSW Steel  906.85  (0.57%)
 
Kotak Mah. Ban..  1702.25  (-0.51%)
 
Larsen & Toubr..  3657.05  (0.17%)
 
M & M  2552.20  (0.17%)
 
Maruti Suzuki  12821.70  (-0.63%)
 
Nestle India  2451.65  (-0.34%)
 
NTPC  365.30  (-1.16%)
 
Power Grid Cor..  312.80  (-1.64%)
 
Reliance Indus..  2911.25  (-0.72%)
 
St Bk of India  830.90  (-0.38%)
 
Sun Pharma.Ind..  1464.85  (-0.13%)
 
Tata Motors  947.30  (-1.12%)
 
Tata Steel  174.85  (-0.37%)
 
TCS  3840.00  (-0.17%)
 
Tech Mahindra  1316.75  (-0.97%)
 
Titan Company  3409.15  (0.16%)
 
UltraTech Cem.  10168.95  (-0.56%)
 
Wipro  456.00  (0.76%)
 
««+1 ««-1
 
Your results on : Equity | News | Company-News
Granules India arm receives USFDA approval for Colchicine Capsules, 0.6 mg     Back
(30 Apr 2024)
Granules India announced today that the US Food & Drug Administration (US FDA) has approved its Abbreviated New Drug Application (ANDA), filed by Granules Pharmaceuticals, Inc. (GPI), a wholly owned foreign subsidiary of the Company, for Colchicine Capsules, 0.6 mg. It is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Mitigare Capsules, 0.6 mg of Hikma International Pharmaceuticals LLC (Hikma).

Colchicine Capsules are indicated for prophylaxis of gout flares in adults.

Granules now have a total of 64 ANDA approvals from the US FDA (63 Final approvals and 1 tentative approvals).

The current annual U.S. market for Colchicine Capsules is approximately $55 Million, according to MAT Feb 2024, IQVIA/IMS Health.

Top
 
 
Related Links : BSE | NSE | SEBI | MoF | MCX | MSEI | NCDEX | CDSL | NSDL | RBI | Cyber Security-SEBI | SEBI SCORES
e-Voting | KYC Process | Investor grievance Redressal - Offline | Investor grievance Redressal - Online (Smart ODR) 		Contact Us | Disclaimer | Site Map | Policies & Procedures
KYC Application Forms in Vernacular Languages | Investor Charter | Client Bank Account Details | Customer Care
SEBI Regn. Nos - NSE(cash) : INB 230648719 | NSE(F&O) : INF 230648719 | BSE(cash), BSE(F&O), BSE (DP) : INZ000216630 | MCX Currency : INE 260648719 | CDSL : IN-DP-CDSL-2
Copyright © 2012 Churiwala Securities , All rights reserved.       Designed, developed and powered by C-MOTS Infotech (ISO 9001:2015 certified)